Data at ADA 2026 Highlights Key Findings from Clinical and RealWorld Studies of MannKinds Afrezza (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
Builds on recent FDA approval (May 29, 2026) of Afrezza for use…
